APC c.695_696delinsAT ;(p.R232H)

Variant ID: 5-112128192-GA-AT

NM_000038.5(APC):c.695_696delinsAT;(p.R232H)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma.

F1000Research
Tripathi, Shashwat S; Najem, Hinda H; Mahajan, Akanksha Sanjay AS; Zhang, Peng P; Low, Justin T JT; Stegh, Alexander H AH; Curran, Michael A MA; Ashley, David M DM; James, Charles David CD; Heimberger, Amy B AB
Publication Date: 2022

Variant appearance in text: APC: R232H
PubMed Link: 36324813
Variant Present in the following documents:
  • Main text
  • f1000research-11-137441.pdf
View BVdb publication page



Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.

Frontiers In Immunology
Abraham, Jinu J; Botto, Sara S; Mizuno, Nobuyo N; Pryke, Kara K; Gall, Bryan B; Boehm, Dylan D; Sali, Tina M TM; Jin, Haihong H; Nilsen, Aaron A; Gough, Michael M; Baird, Jason J; Chakhtoura, Marita M; Subra, Caroline C; Trautmann, Lydie L; Haddad, Elias K EK; DeFilippis, Victor R VR
Publication Date: 2020

Variant appearance in text: APC: R232H
PubMed Link: 32733475
Variant Present in the following documents:
  • fimmu-11-01430.pdf
View BVdb publication page



The host STING pathway at the interface of cancer and immunity.

The Journal Of Clinical Investigation
Corrales, Leticia L; McWhirter, Sarah M SM; Dubensky, Thomas W TW; Gajewski, Thomas F TF
Publication Date: 2016-07-01

Variant appearance in text: APC: R232H
PubMed Link: 27367184
Variant Present in the following documents:
  • Main text
View BVdb publication page